Atrial Fibrillation

This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower  ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion

News | EP Mapping and Imaging Systems

July 5, 2019 — Single-use cardiology medical device reprocessing company Innovative Health, received U.S. Food and Drug ...

Home July 05, 2019
Home
News | Cardiovascular Clinical Studies

July 3, 2019 — The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to ...

Home July 03, 2019
Home
News | Implantable Cardiac Monitor (ICM)

July 1, 2019 – Biotronik announced the European market release of its new injectable cardiac monitor (ICM), Biomonitor ...

Home July 01, 2019
Home
Videos | Atrial Fibrillation

Sanjaya Gupta, M.D., electrophysiologist, St. Luke's Mid America Heart Institute, and assistant professor, University of ...

Home June 21, 2019
Home
News | Patient Engagement

June 17, 2019 – Initial results from the AVIATOR 2 international registry were presented as late-breaking clinical ...

Home June 17, 2019
Home
News | Left Atrial Appendage (LAA) Occluders

June 12, 2019 — Boston Scientific Corp. has initiated the OPTION trial to compare safety and effectiveness of the next ...

Home June 12, 2019
Home
News | EP Mapping and Imaging Systems

May 28, 2019 — Researchers have developed the first algorithm that can locate patient-specific ablation targets for atri ...

Home May 28, 2019
Home
News | Renal Denervation

May 23, 2019 – Investigators unveiled late-breaking clinical data from a first-of-its-kind physician sponsored clinical ...

Home May 23, 2019
Home
News | ECG Monitoring Services

May 16, 2019 — Preventice Solutions presented clinical data validating its BodyGuardian Remote Monitoring System with ...

Home May 16, 2019
Home
Technology | Analytics Software

May 16, 2019 — Johnson & Johnson Medical Devices Companies announced the launch of Biosense Webster Inc.’s Cartonet to ...

Home May 16, 2019
Home
Blog | HRS

 


The Heart Rhythm Society (HRS) 2019 Annual Scientific Sessions represent an important annual event for electrophysi ...

Home May 16, 2019
Home
News

May 16, 2019 — Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter ...

Home May 16, 2019
Home
News

May 16, 2019 — CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the ...

Home May 16, 2019
Home
HRS 2019 late breaking trials, late breaking presentations for the biggest news in electrophysiology (EP). #HRS #HRS2019 #HRS19
Feature | HRS | Dave Fornell, Editor

May 15, 2019 — The Heart Rhythm Society (HRS) had 21 late-breaking study presentations at the 2019 Heart Rhythm ...

Home May 15, 2019
Home
News | Atrial Fibrillation | Dave Fornell, Editor

May 15, 2019 — Renal artery denervation (RDN) was found to be safe when employed with pulmonary vein isolation (PVI) to ...

Home May 15, 2019
Home
Subscribe Now